Cloudbreak Pharmaceutical
Research - Irvine, California, United States
Cloudbreak Pharmaceutical Employees
Cloudbreak Pharmaceutical Details
Cloudbreak Pharmaceutical is a clinical-stage biotechnology company focusing on ocular drug development. We have always adhered to our mission - to help people enjoy life better visually through medication. First founded in 2015 in California, USA as a research and development base, Cloudbreak Pharmaceutical further established a research and development base in Guangzhou, China in 2018 and is establishing a production base in Suzhou, China. The core development team members of Cloudbreak Pharmaceuticals came from the world-renowned ophthalmic pharmaceutical company Allergan, and other pharmaceutical companies including Pfizer, Santen and Amgen. They have extensive experience in research, development, clinical, registration and commercialization of new ophthalmic drugs. With the "Global market global lead" vision, Cloudbreak Pharma independently developed a variety of internationally leading first in class and best in class new ophthalmic drugs. The company's various products, including CBT-001, CBT-004, CBT-006 and CBT-008, are undergoing clinical phase III and phase II trials in the United States.
Cloudbreak Pharmaceutical Technologies
Email Providers
Outlook
CMS
WordPress.org
Other
Mobile Friendly
Hosting
Google Cloud Hosting